Thu, Apr 17, 2014, 1:04 PM EDT - U.S. Markets close in 2 hrs 56 mins

Recent

% | $
Quotes you view appear here for quick access.

Pfizer Inc. Message Board

cyoung8404 144 posts  |  Last Activity: 15 minutes ago Member since: Sep 14, 2009
  • Reply to

    Gilead's Solvadi pricing

    by cyoung8404 Mar 24, 2014 5:02 PM
    cyoung8404 cyoung8404 Mar 25, 2014 8:11 AM Flag

    Frank, I believe you are now implying that most people who got HEP C were the "1960's Free Love" crowd. I have a family member who got Hep C as a teenager after receiving blood transfusions while having her leg amputated due to a cancerous tumor. Luckily, she got into a Schering Plough research treatment program 15 years ago and is now virus free. You know, Frank, you are one of the most insensitive and sleazy people I have ever encountered. You find it so easy to sit behind your computer and spew out your crappola. Tells me a lot about what kind of character (or lack of it) you possess. Just hope that when your time comes, you get judged by the same "standards" you judge everyone else by.

  • Reply to

    Gilead's Solvadi pricing

    by cyoung8404 Mar 24, 2014 5:02 PM
    cyoung8404 cyoung8404 Mar 25, 2014 7:59 AM Flag

    Frank, baby, if you read my post, I clearly stated that the 168K figure was for SIX MONTHS of treatment which is sometimes necessary. So just multiply 2x's the 84K and you get 168K. That make sense to you, right? I cited a very recent NY Times article explaining the situation. I would go back and cite the date of the article which I believe was two days ago, but I won't bother wasting time trying to argue with the likes of you. Just keep living in your biased fantasy world, and the rest of us can let your own language and ignorance determine who the real douche bag is on this message board. I love it when you lose your cool. It just makes my day. Look forward to talking to you tomorrow.

  • cyoung8404 by cyoung8404 Mar 24, 2014 5:06 PM Flag

    Sorry

  • cyoung8404 by cyoung8404 Mar 24, 2014 5:02 PM Flag

    The government's scrutiny of Gilead's pricing of its Hep C drug appears to be one of the catalysts of the bio-tech sell off. According to a report in the NY Times, a six month treatment of the drug in the US will cost $168,000. It is estimated that the same treatment will cost $2,000 in India. The rest of the world will have prices somewhere between those of India and the US. Although the sell off has cost me some money, it is understandable that the government question why our patients, Medicare, and insurance companies have to pay the highest prices. Recently I have talked to people who take vacations to other countries just to have medical work done. A niece of mine takes a yearly vacation to Israel to visit family and have any needed dental work done. She says that the money she saves on dental insurance and treatment cost practically pays for her vacation.

  • Reply to

    Is Michelle still in China?

    by frankfrazzano Mar 24, 2014 3:17 PM
    cyoung8404 cyoung8404 Mar 24, 2014 4:43 PM Flag

    Well said, sbacchus. I believe guys like Frank are very hurtful to the Republican Party and democracy as a whole. He obviously is on the extreme fringe of the party, but his totally biased rants don't sit well with intelligent voters. He actually pushes people to vote the other way.

  • Frank, it is amazing how even though your bio-techs are getting killed, you still find time to let your bias and hatred come out. You are the one guy I can count on to show that absurdity just doesn't take a break. Anyone with a brain can see you totally slant things to "try" to support your assertions. At least you weren't bragging about how you made all the right stock moves all the time for a change.

  • Reply to

    Unbelieveable

    by vpg1720 Mar 24, 2014 9:46 AM
    cyoung8404 cyoung8404 Mar 24, 2014 10:24 AM Flag

    Thanks, he is a good guy and a father of a young teen. I don't know, but it seems like more people are getting brain cancer these days. We have had three friends/neighbors get it in the last few years. All three were comparatively young, 50's and early 60's. One has died, and one has survived for about 5 years with a lot of treatments that have basically bankrupted her. Friends and neighbors have been raising money for her expenses. She lost her health insurance when the pharmaceutical company she worked for laid her off. I hope the Affordable Health Care Act helps her get insurance that she can afford.

  • Reply to

    Unbelieveable

    by vpg1720 Mar 24, 2014 9:46 AM
    cyoung8404 cyoung8404 Mar 24, 2014 10:05 AM Flag

    Bio-tech sector is really getting pounded. I am out of Cldx now, but I do own Cemp and Opk. I have been trading in and out of them, so I am only feeling a little pain now. I like both of them because they have approvals (hopefully) in the near future. I have always liked Cldx, but the stock appears to have run way too high on long term speculation. I have been in and out of the stock for many years, but approvals still seem too far off to protect it from this bio-tech sell off. I hope the stock rebounds for long term investors and for the cancer patients it may benefit. A friend of mine was just diagnosed with brain cancer, so his life may depend on it. He had surgery at the Anderson Hospital in Houston, and he is awaiting what comes next. I'll let you know if they involve him in any Cldx trials.

  • cyoung8404 cyoung8404 Mar 21, 2014 12:28 PM Flag

    Frank, the market is soaring. Just because you put all your marbles in a highly speculative sector, don't blame the Prez. My bank stocks are doing just fine and the dividends are quite nice. Maybe you should put a little $ in BTO before it is too late.

  • He was intrigued by the possibilities a better predictor of prostate cancer would hold. If 4K score replaces the fairly unreliable PSA test, Opk could be in for a big pay day.

  • I guess the good doctor has the funds to keep this up on a regular basis. I have never seen someone put their money into play like he does. Sure must make the shorts nervous, for who better than Frost knows where Opk is headed. It would be suicidal for him to keep throwing his money at Opk if he had any doubts at all concerning Opk's future prospects. IMHO.

  • Yesterday's purchase was another sign that the good doctor really believes in this company. I took today's mini-dip to join him in adding more. Someone I know dealt with Frost years back in connection with a sale of one of his companies. The person was very impressed with Frost's business smarts. Not many insiders keep buying no matter what the price. That tells me that Frost believes this company is headed much higher from where we presently sit. Opk is the opposite of Gale where insiders were dumping while they hired a PR company to pump the stock. IMHO.

  • Reply to

    Nice article out on SA

    by tadpolefun Mar 18, 2014 6:27 PM
    cyoung8404 cyoung8404 Mar 18, 2014 7:17 PM Flag

    He obviously was disappointed in that Gale insiders apparently put greed ahead of the welfare of their company and the cancer patients who may benefit from their drugs if they actually work. I am skeptical because if their science is that good, these guys would make far more buy buying and holding than they would by pumping and dumping. I like guys like Dr. Frost of OPKO who continually buys shares on just about a weekly basis. He believes in his company, and he puts his money at risk just like the ordinary investor. IMHO.

  • Reply to

    Holding the Line on Low Volume

    by fitzdad55 Mar 17, 2014 4:55 PM
    cyoung8404 cyoung8404 Mar 17, 2014 6:05 PM Flag

    I think it means that Friday's trading is just a little taste of what will happen when Icahn decides to tweet some significant news about his plans for Nuan. Shorts will be toast.

  • cyoung8404 cyoung8404 Mar 17, 2014 11:28 AM Flag

    I believe there was a very strong trade imbalance to the upside. The market seemed to think that substantial news was pending. I believe someone placed a trade for well over 800,000 shares that made the price spike very quickly. Most people think Icahn will make some kind of play here, so I think speculators rushed in. Even with the jump in price, I view NUAN as attractive because of its products and Icahn's involvement. IMHO.

  • Reply to

    16$ in last trading minutes ...

    by rxxxxj Mar 14, 2014 3:51 PM
    cyoung8404 cyoung8404 Mar 14, 2014 11:53 PM Flag

    There were certainly a lot of buyers today. Glad I am long and not short. If CI has something up his sleeves, shorts could be toast big time.

  • cyoung8404 cyoung8404 Mar 14, 2014 11:51 PM Flag

    It wouldn't be the first company Dr. Frost sold, but I don't think he is ready to sell yet. With two big prospects nearing the market, OPK should fetch far more down the road. IMHO.

  • Reply to

    RIO speaks on Oyu Tolgoi

    by mayberrygooddad Mar 13, 2014 4:38 PM
    cyoung8404 cyoung8404 Mar 14, 2014 11:48 PM Flag

    Sooner or later it would make sense for Rio to buyout TRQ and do what they want with the mine. I guess it just depends on when and how much Rio would be willing to pay. With copper prices going down and MG hard to deal with, Rio seems to be playing hardball. However, now might be the perfect time to buyout TRQ for a modestly higher offer. I think most shareholders would be interested if a $6 - $8 offer was made. We shall see.

  • Reply to

    just wondering who paid 16.68 today.

    by jk4763 Mar 14, 2014 1:51 PM
    cyoung8404 cyoung8404 Mar 14, 2014 2:21 PM Flag

    We are headed over $16 again. That $16.68 price may look good by the end of the day.

  • This thing could really break out. This morning's trading took out most of the sellers up to the mid $16 level. Might as well cover now because you know CI is going to pump NUAN up one way or another. IMHO.

PFE
30.34+0.25(+0.83%)1:03 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.